{"id":"dibutylsuccinate","rwe":[],"tags":[{"label":"dibutylsuccinate","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"P03BX04","category":"atc"},{"label":"Active","category":"status"}],"phase":"unknown","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"dibutyl succinate","offLabel":[],"synonyms":["dibutylsuccinate","dibutyl succinate"],"timeline":[],"approvals":[],"brandName":"Dibutyl Succinate","ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"dibutylsuccinate","explanation":"Imagine your cells are like a city with many different buildings and roads. Dibutyl Succinate is like a traffic controller that helps regulate the flow of information and materials between the different parts of the city. By doing so, it may help to restore balance and function to the cells, but more research is needed to confirm this idea.","oneSentence":"Dibutyl Succinate is thought to work by modulating cellular processes, but its exact mechanism of action is not well understood.","technicalDetail":"Dibutyl Succinate is a small molecule that interacts with cellular targets to modulate signaling pathways and influence gene expression, but the specific molecular mechanisms underlying its effects are not yet fully elucidated."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/4415","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=dibutylsuccinate","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T10:33:45.474139","biosimilars":[],"competitors":[{"drugName":"diethyltoluamide","drugSlug":"diethyltoluamide","fdaApproval":"","relationship":"same-class"}],"genericName":"dibutylsuccinate","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"diethyltoluamide","brandName":"diethyltoluamide","genericName":"diethyltoluamide","approvalYear":"","relationship":"same-class"}],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"Q050512U41","CHEBI":"CHEBI:82263","UMLSCUI":"C0301186","ChEMBL_ID":"CHEMBL1788388","DRUGBANK_ID":"DB13332","PUBCHEM_CID":"8830"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Other"],"atcClassification":{"source":"DrugCentral","atcCode":"P03BX04","allCodes":["P03BX04"]},"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"unknown","modality":"Small Molecule","firstApprovalDate":"","aiSummary":"Dibutyl Succinate is a small molecule drug of the dibutylsuccinate class, but information on its development, commercial status, and approved indications is limited. As a result, there is no clear understanding of its target, mechanism of action, or clinical use. Further research is needed to determine its potential therapeutic applications and safety profile. The current owner of dibutyl succinate is unknown, and it has not been approved by the FDA. More information is required to assess its commercial status and potential as a treatment option.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}